Cme Group Stock Analysis
CME Stock | USD 274.70 3.12 1.12% |
CME Group is overvalued with Real Value of 250.95 and Target Price of 271.12. The main objective of CME stock analysis is to determine its intrinsic value, which is an estimate of what CME Group is worth, separate from its market price. There are two main types of CME's stock analysis: fundamental analysis and technical analysis.
The CME stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CME's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. CME Stock Analysis Notes
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of CME was currently reported as 75.16. The company recorded earning per share (EPS) of 9.95. CME Group last dividend was issued on the 9th of June 2025. The entity had 5:1 split on the 23rd of July 2012. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people. For more info on CME Group please contact the company at 312 930 1000 or go to https://www.cmegroup.com.CME Quarterly Total Revenue |
|
CME Group Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. CME's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding CME Group or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 92.0% of the company shares are held by institutions such as insurance companies | |
On 25th of June 2025 CME paid $ 1.25 per share dividend to its current shareholders | |
Latest headline from thelincolnianonline.com: Graypoint LLC Raises Stake in CME Group Inc. |
CME Group Upcoming and Recent Events
14th of February 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
14th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
CME Largest EPS Surprises
Earnings surprises can significantly impact CME's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2003-07-22 | 2003-06-30 | 0.19 | 0.21 | 0.02 | 10 | ||
2003-04-22 | 2003-03-31 | 0.13 | 0.15 | 0.02 | 15 | ||
2004-04-27 | 2004-03-31 | 0.24 | 0.27 | 0.03 | 12 |
CME Environmental, Social, and Governance (ESG) Scores
CME's ESG score is a quantitative measure that evaluates CME's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of CME's operations that may have significant financial implications and affect CME's stock price as well as guide investors towards more socially responsible investments.
CME Thematic Classifications
In addition to having CME stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | BlockchainCross-industry collection of firms that are adopting blockchain technology |
CME Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Capital Research & Mgmt Co - Division 3 | 2025-03-31 | 4.4 M | Northern Trust Corp | 2025-03-31 | 3.8 M | Arrowstreet Capital Limited Partnership | 2025-03-31 | 3.6 M | Fidelity International Ltd | 2025-03-31 | 3.6 M | Franklin Resources Inc | 2025-03-31 | 3.4 M | Royal Bank Of Canada | 2025-03-31 | 3.3 M | Goldman Sachs Group Inc | 2025-03-31 | 3.1 M | Ubs Group Ag | 2025-03-31 | 3 M | Mitsubishi Ufj Asset Management Co.,ltd | 2025-03-31 | 2.9 M | Vanguard Group Inc | 2025-03-31 | 34.6 M | Blackrock Inc | 2025-03-31 | 32.6 M |
CME Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 98.99 B.CME Profitablity
The company has Net Profit Margin of 0.58 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.68 %, which entails that for every 100 dollars of revenue, it generated $0.68 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.06 | |
Return On Capital Employed | 0.11 | 0.17 | |
Return On Assets | 0.03 | 0.03 | |
Return On Equity | 0.13 | 0.13 |
Management Efficiency
CME Group has Return on Asset of 0.0176 % which means that on every $100 spent on assets, it made $0.0176 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1339 %, implying that it generated $0.1339 on every 100 dollars invested. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities. At present, CME's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.03, whereas Return On Equity is forecasted to decline to 0.13. At present, CME's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 104.4 B, whereas Other Assets are forecasted to decline to about 146.8 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 73.70 | 39.50 | |
Tangible Book Value Per Share | (3.27) | (3.43) | |
Enterprise Value Over EBITDA | 18.21 | 14.22 | |
Price Book Value Ratio | 3.15 | 3.78 | |
Enterprise Value Multiple | 18.21 | 14.22 | |
Price Fair Value | 3.15 | 3.78 | |
Enterprise Value | 60.2 B | 63.3 B |
CME Group has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Technical Drivers
As of the 19th of July, CME shows the Risk Adjusted Performance of 0.0614, downside deviation of 1.44, and Mean Deviation of 0.8549. CME Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CME Group downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if CME Group is priced adequately, providing market reflects its regular price of 274.7 per share. Given that CME has jensen alpha of 0.0773, we suggest you to validate CME Group's prevailing market performance to make sure the company can sustain itself in the future.CME Group Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of CME for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out CME Group short-term fluctuations and highlight longer-term trends or cycles.
CME Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CME insiders, such as employees or executives, is commonly permitted as long as it does not rely on CME's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CME insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mccourt Timothy Francis over six months ago Disposition of tradable shares by Mccourt Timothy Francis of CME at 206.775 subject to Rule 16b-3 | ||
Mccourt Timothy Francis over a year ago Disposition of tradable shares by Mccourt Timothy Francis of CME at 217.5 subject to Rule 16b-3 | ||
Julie Winkler over a year ago Acquisition by Julie Winkler of 3808 shares of CME subject to Rule 16b-3 | ||
Julie Winkler over a year ago Payment of 1513 shares by Julie Winkler of CME subject to Rule 16b-3 |
CME Outstanding Bonds
CME issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CME Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CME bonds can be classified according to their maturity, which is the date when CME Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
CME GROUP INC Corp BondUS12572QAF28 | View | |
CME GROUP INC Corp BondUS12572QAH83 | View | |
CME GROUP INC Corp BondUS12572QAJ40 | View | |
CME 265 15 MAR 32 Corp BondUS12572QAK13 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
CME Predictive Daily Indicators
CME intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CME stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 32825.52 | |||
Daily Balance Of Power | (0.75) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 276.38 | |||
Day Typical Price | 275.82 | |||
Price Action Indicator | (3.24) | |||
Period Momentum Indicator | (3.12) | |||
Relative Strength Index | 56.69 |
CME Corporate Filings
F4 | 26th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 11th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 23rd of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 21st of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 20th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 19th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 9th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
7th of May 2025 Other Reports | ViewVerify |
CME Forecast Models
CME's time-series forecasting models are one of many CME's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CME's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CME Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CME prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CME shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CME. By using and applying CME Stock analysis, traders can create a robust methodology for identifying CME entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.74 | 0.44 | |
Operating Profit Margin | 0.64 | 0.43 | |
Net Profit Margin | 0.58 | 0.32 | |
Gross Profit Margin | 0.86 | 0.66 |
Current CME Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CME analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CME analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
271.12 | Buy | 18 | Odds |
Most CME analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CME stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CME Group, talking to its executives and customers, or listening to CME conference calls.
CME Stock Analysis Indicators
CME Group stock analysis indicators help investors evaluate how CME stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CME shares will generate the highest return on investment. By understating and applying CME stock analysis, traders can identify CME position entry and exit signals to maximize returns.
Begin Period Cash Flow | 93.1 B | |
Long Term Debt | 2.7 B | |
Common Stock Shares Outstanding | 359.9 M | |
Total Stockholder Equity | 26.5 B | |
Total Cashflows From Investing Activities | -82.6 M | |
Tax Provision | 1 B | |
Quarterly Earnings Growth Y O Y | 0.115 | |
Property Plant And Equipment Net | 386.2 M | |
Cash And Short Term Investments | 3 B | |
Cash | 2.9 B | |
Accounts Payable | 79.9 M | |
Net Debt | 535.6 M | |
50 Day M A | 276.7148 | |
Total Current Liabilities | 102.3 B | |
Other Operating Expenses | 1.5 B | |
Non Current Assets Total | 34.4 B | |
Forward Price Earnings | 25.1889 | |
Non Currrent Assets Other | 6.4 B | |
Stock Based Compensation | 89.5 M |
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |